Home LiteratureArticle Details
PMID: 16943440 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.

Molecular and cellular biology ·Vol. 26 ·No. 18 ·2006-09-00 ·Pages 7005-15

Ho GP, Margossian S, Taniguchi T, D'Andrea AD

Abstract

The Fanconi anemia (FA) pathway is a DNA damage-activated signaling pathway which regulates cellular resistance to DNA cross-linking agents. Cloned FA genes and proteins cooperate in this pathway, and monoubiquitination of FANCD2 is a critical downstream event. The cell cycle checkpoint kinase ATR is required for the efficient monoubiquitination of FANCD2, while another checkpoint kinase, ATM, directly phosphorylates FANCD2 and controls the ionizing radiation (IR)-inducible intra-S-phase checkpoint. In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents. Phosphorylation of the sites is required for establishment of the intra-S-phase checkpoint response. IR-inducible phosphorylation of threonine 691 and serine 717 is also dependent on ATM and is more strongly impaired when both ATM and ATR are knocked down. Threonine 691 is phosphorylated during normal S-phase progression in an ATM-dependent manner. These findings further support the functional connection of ATM/ATR kinases and FANCD2 in the DNA damage response and support a role for the FA pathway in the coordination of the S phase of the cell cycle.

MeSH Terms
Amino Acid Sequence Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins/metabolism Cells, Cultured Cross-Linking Reagents/pharmacology DNA Damage DNA-Binding Proteins/metabolism Drug Resistance, Neoplasm Fanconi Anemia Complementation Group D2 Protein/chemistry,metabolism HeLa Cells Humans Mitomycin/pharmacology Molecular Sequence Data Nuclear Proteins/metabolism Phosphorylation/drug effects,radiation effects Protein Serine-Threonine Kinases/metabolism S Phase/drug effects,radiation effects Serine/metabolism Threonine/metabolism Tumor Suppressor Proteins/metabolism Ubiquitin/metabolism Ultraviolet Rays
Chemicals
Cell Cycle Proteins Cross-Linking Reagents DNA-Binding Proteins Fanconi Anemia Complementation Group D2 Protein NBN protein, human Nuclear Proteins Tumor Suppressor Proteins Ubiquitin Threonine Serine Mitomycin ATM protein, human ATR protein, human Ataxia Telangiectasia Mutated Proteins Protein Serine-Threonine Kinases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ho Gary P H
Dana-Farber Cancer Institute, Department of Radiation Oncology, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Margossian Steven
Taniguchi Toshiyasu
D'Andrea Alan D
References (44)
44 references, click to expand
  1. A novel ubiquitin ligase is deficient in Fanconi anemia.
    Nat Genet. 2003 Oct;35(2):165-70 PMID: 12973351
  2. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
    Blood. 2003 Jul 1;102(1):136-41 PMID: 12649160
  3. ATR and ATM regulate the timing of DNA replication origin firing.
    Nat Cell Biol. 2004 Jul;6(7):648-55 PMID: 15220931
  4. ATR couples FANCD2 monoubiquitination to the DNA-damage response.
    Genes Dev. 2004 Aug 15;18(16):1958-63 PMID: 15314022
  5. FANCG is phosphorylated at serines 383 and 387 during mitosis.
    Mol Cell Biol. 2004 Oct;24(19):8576-85 PMID: 15367677
  6. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation.
    Int J Radiat Biol Relat Stud Phys Chem Med. 1981 May;39(5):547-58 PMID: 6972365
  7. Fragments of ATM which have dominant-negative or complementing activity.
    Mol Cell Biol. 1997 Apr;17(4):2020-9 PMID: 9121450
  8. Recombinant ATM protein complements the cellular A-T phenotype.
    Oncogene. 1997 Jul 10;15(2):159-67 PMID: 9244351
  9. Enhanced phosphorylation of p53 by ATM in response to DNA damage.
    Science. 1998 Sep 11;281(5383):1674-7 PMID: 9733514
  10. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
    Science. 1998 Sep 11;281(5383):1677-9 PMID: 9733515
  11. Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.
    Mol Cell Biol. 1998 Oct;18(10):5952-60 PMID: 9742112
  12. The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13085-90 PMID: 9789045
  13. The Fanconi anemia core complex associates with chromatin during S phase.
    Blood. 2005 Jan 15;105(2):759-66 PMID: 15256425
  14. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
    Blood. 2005 Feb 1;105(3):1003-9 PMID: 15454491
  15. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair.
    Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5 PMID: 15650050
  16. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.
    Mol Cell. 2005 Feb 4;17(3):331-9 PMID: 15694335
  17. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.
    Mol Cell Biol. 2005 May;25(9):3553-62 PMID: 15831461
  18. ATM and ATR check in on origins: a dynamic model for origin selection and activation.
    Cell Cycle. 2005 Feb;4(2):235-8 PMID: 15655372
  19. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1.
    Mol Cell Biol. 2005 Jul;25(13):5363-79 PMID: 15964794
  20. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.
    Nat Genet. 2005 Sep;37(9):953-7 PMID: 16116421
  21. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
    Nat Genet. 2005 Sep;37(9):958-63 PMID: 16116422
  22. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
    Nat Genet. 2005 Sep;37(9):934-5 PMID: 16116423
  23. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Nat Genet. 2005 Sep;37(9):931-3 PMID: 16116424
  24. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Nat Struct Mol Biol. 2005 Sep;12(9):763-71 PMID: 16116434
  25. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.
    Cancer Cell. 2005 Sep;8(3):255-65 PMID: 16153896
  26. The Fanconi Anemia/BRCA pathway: new faces in the crowd.
    Genes Dev. 2005 Dec 15;19(24):2925-40 PMID: 16357213
  27. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.
    Science. 1999 Nov 5;286(5442):1162-6 PMID: 10550055
  28. Substrate specificities and identification of putative substrates of ATM kinase family members.
    J Biol Chem. 1999 Dec 31;274(53):37538-43 PMID: 10608806
  29. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
    Nature. 2000 Apr 6;404(6778):613-7 PMID: 10766245
  30. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products.
    Nature. 2000 May 25;405(6785):473-7 PMID: 10839544
  31. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.
    Nature. 2000 May 25;405(6785):477-82 PMID: 10839545
  32. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Cancer Res. 2000 Jun 15;60(12):3299-304 PMID: 10866324
  33. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.
    Biochem Biophys Res Commun. 2001 Feb 23;281(2):347-51 PMID: 11181053
  34. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
    Mol Cell. 2001 Feb;7(2):249-62 PMID: 11239454
  35. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.
    Mol Cell Biol. 2001 May;21(10):3445-50 PMID: 11313470
  36. The emerging genetic and molecular basis of Fanconi anaemia.
    Nat Rev Genet. 2001 Jun;2(6):446-57 PMID: 11389461
  37. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.
    Genes Dev. 2002 Mar 1;16(5):560-70 PMID: 11877376
  38. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.
    Genes Dev. 2002 Mar 1;16(5):571-82 PMID: 11877377
  39. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
    Cell. 2002 May 17;109(4):459-72 PMID: 12086603
  40. FANCE: the link between Fanconi anaemia complex assembly and activity.
    EMBO J. 2002 Jul 1;21(13):3414-23 PMID: 12093742
  41. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.
    Blood. 2002 Oct 1;100(7):2414-20 PMID: 12239151
  42. The Fanconi anaemia/BRCA pathway.
    Nat Rev Cancer. 2003 Jan;3(1):23-34 PMID: 12509764
  43. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.
    Mol Cell Biol. 2003 May;23(10):3417-26 PMID: 12724401
  44. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.
    Mol Cell Biol. 2004 Jul;24(13):5850-62 PMID: 15199141
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2006-09-00
Pages
7005-15
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC1592857
Subset
IM
Grants
NHLBI NIH HHS · P01 HL 54785 · United States
NIDDK NIH HHS · R01 DK 43889 · United States
NHLBI NIH HHS · R01 HL 52725 · United States
NHLBI NIH HHS · R01 HL052725 · United States
NCI NIH HHS · P50 CA 205009-01 · United States
NCI NIH HHS · P50 CA105009 · United States
NHLBI NIH HHS · P50 HL054785 · United States
PHS HHS · P01 50654 · United States
NIDDK NIH HHS · R01 DK043889 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]